Completed from United Kingdom
I signed up for this course hoping to get a solid grounding in health‑economic evaluation, and it delivered exactly that—plus a few pleasant surprises. The lectures on budget impact analysis were broken down into bite‑size chunks, and the practical workshop where we built a simple Markov model in R was a highlight. I now feel equipped to run cost‑utility analyses for NHS formularies, and the supplementary reading list kept me up‑to‑date with UK NICE guidelines. The only thing missing was a bit more focus on data‑visualisation, but overall it was a very worthwhile investment.
The Pharmaceutical Health Economics course perfectly aligned with my goal of mastering cost‑effectiveness analysis for new drug submissions. The modules on incremental cost‑effectiveness ratios and willingness‑to‑pay thresholds gave me a clear framework that I immediately applied to a real‑world case study on oncology therapies. The provided Excel templates were polished and ready for industry use, saving me hours of model building. Overall, the material was current, the instructor’s examples were directly relevant to US FDA expectations, and I left the course confident in presenting health‑economic dossiers to senior management.
Wow! This course blew me away with its practical, hands‑on approach. I wanted to learn how to assess the economic value of biotech products for the Indian market, and the instructor walked us through a full health‑technology assessment, from data collection to sensitivity analysis, using real Indian epidemiological data. The interactive case where we evaluated a hepatitis‑C treatment using a decision‑tree model gave me confidence to present a budget impact report to my company's senior leadership. The video lectures were crisp, the downloadable slide decks were beautifully designed, and the community forum was buzzing with useful tips. I'm thrilled with what I’ve learned!
The course offered a detailed exploration of the theoretical underpinnings of health economics as well as concrete tools for implementation. I appreciated the thorough coverage of discounting methods, the step‑by‑step guide to constructing a cost‑benefit analysis for a public‑health vaccination program, and the extensive bibliography that included African health‑policy documents. The practical assignments, especially the one where we performed a probabilistic sensitivity analysis using @RISK, helped cement my understanding and gave me a portfolio piece to show prospective employers. While the pacing was brisk, the quality of the materials and the relevance to South African health‑system challenges made it an excellent learning experience.
